Analysts Offer Predictions for SAGE Q1 Earnings
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Wedbush issued their Q1 2026 earnings estimates for Sage Therapeutics in a report released on Wednesday, April 16th. Wedbush analyst L. Chico expects that the biopharmaceutical company will post earnings per share of ($0.75) for the quarter. Wedbush has a “Neutral” rating and a […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Wedbush issued their Q1 2026 earnings estimates for Sage Therapeutics in a report released on Wednesday, April 16th. Wedbush analyst L. Chico expects that the biopharmaceutical company will post earnings per share of ($0.75) for the quarter. Wedbush has a “Neutral” rating and a […]
